Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year

References 

1. Barry DT, Moore BA, Pantalon MV, et al. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. Journal of General Internal Medicine. 2007;22:242–245
   • CrossRef
2. Cunningham C, Giovanniello A, Sacajiu G, et al. Buprenorphine treatment in an urban community health center: What to expect. Family Medicine. 2008;40:500–506
3. Fiellin DA, Moore BA, Sullivan LE, et al. Long-term treatment with buprehorphine/naloxone in primary care: Results at 2–5 years. American Journal on Addiction. 2008;17:116–120
4. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine–naloxone therapy for opioid dependence. New England Journal of Medicine. 2006;355:365–374
5. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine. 2003;349:949–958
6. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Review. 2003;CD002209
7. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Review. 2008;CD002207
8. Mintzer I, Eisenberg M, Terra M, MacVane C, Himmelstein D, Woolhandler S. Treating opioid addiction with buprenorphine–naloxone in community-based primary care settings. Annals of Family Medicine. 2007;5:146–150
   • CrossRef
9. Moore BA, Fiellin DA, Barry DT, et al. Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine. 2007;22:527–530
   • CrossRef
10. O'Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine. 1998;105:100–105
11. Renzelli CM, Capretto NA. Less pain, more gain: Buprenorphine–Naloxone and patient retention in treatment. Journal of Addictive Diseases. 2006;25:97–104
    • MEDLINE
    • CrossRef
12. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. Journal of General Internal Medicine. 2005;20:1038–1041
    • CrossRef
13. Substance Abuse and Mental Health Services Administration . Results from the 2007 National Survey on Drug Use and Health: National Findings. 2008;(Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD
14. Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?. Drug and Alcohol Dependence. 2005;79:113–116
    • Abstract
    • Full Text
    • Full-Text PDF (63 KB)
    • CrossRef